Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets.

Maciejewski M, Lounkine E, Whitebread S, Farmer P, DuMouchel W, Shoichet BK, Urban L.

Elife. 2017 Aug 8;6. pii: e25818. doi: 10.7554/eLife.25818.

2.

Data-driven prediction of adverse drug reactions induced by drug-drug interactions.

Liu R, AbdulHameed MDM, Kumar K, Yu X, Wallqvist A, Reifman J.

BMC Pharmacol Toxicol. 2017 Jun 8;18(1):44. doi: 10.1186/s40360-017-0153-6.

3.

Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms.

Lu Y, Figler B, Huang H, Tu YC, Wang J, Cheng F.

PLoS One. 2017 Apr 19;12(4):e0173548. doi: 10.1371/journal.pone.0173548. eCollection 2017.

4.

Data-Driven Prediction of Beneficial Drug Combinations in Spontaneous Reporting Systems.

Li Y, Zhang P, Sun Z, Hu J.

AMIA Annu Symp Proc. 2017 Feb 10;2016:808-817. eCollection 2016.

5.

Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.

Hameed PN, Verspoor K, Kusljic S, Halgamuge S.

BMC Bioinformatics. 2017 Mar 1;18(1):140. doi: 10.1186/s12859-017-1546-7.

6.

Drug voyager: a computational platform for exploring unintended drug action.

Oh M, Ahn J, Lee T, Jang G, Park C, Yoon Y.

BMC Bioinformatics. 2017 Feb 28;18(1):131. doi: 10.1186/s12859-017-1558-3.

7.

Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.

Han X, Chiang C, Leonard CE, Bilker WB, Brensinger CM, Li L, Hennessy S.

Epidemiology. 2017 May;28(3):459-468. doi: 10.1097/EDE.0000000000000638.

PMID:
28169935
8.

Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data.

Zhang W, Chen Y, Liu F, Luo F, Tian G, Li X.

BMC Bioinformatics. 2017 Jan 5;18(1):18. doi: 10.1186/s12859-016-1415-9.

9.

Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation.

Lorberbaum T, Sampson KJ, Chang JB, Iyer V, Woosley RL, Kass RS, Tatonetti NP.

J Am Coll Cardiol. 2016 Oct 18;68(16):1756-1764. doi: 10.1016/j.jacc.2016.07.761.

10.

MeSHDD: Literature-based drug-drug similarity for drug repositioning.

Brown AS, Patel CJ.

J Am Med Inform Assoc. 2017 May 1;24(3):614-618. doi: 10.1093/jamia/ocw142.

11.

Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.

Federer C, Yoo M, Tan AC.

Assay Drug Dev Technol. 2016 Dec;14(10):557-566. Epub 2016 Sep 15.

12.

Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing.

Udrescu L, Sbârcea L, Topîrceanu A, Iovanovici A, Kurunczi L, Bogdan P, Udrescu M.

Sci Rep. 2016 Sep 7;6:32745. doi: 10.1038/srep32745.

13.

Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods.

Richesson RL, Sun J, Pathak J, Kho AN, Denny JC.

Artif Intell Med. 2016 Jul;71:57-61. doi: 10.1016/j.artmed.2016.05.005. Epub 2016 Jun 25.

14.

Patient-Level Adverse Event Patterns in a Single-Institution Study of the Multi-Kinase Inhibitor Sorafenib.

Karovic S, Shiuan EF, Zhang SQ, Cao H, Maitland ML.

Clin Transl Sci. 2016 Jul 21. doi: 10.1111/cts.12408. [Epub ahead of print]

15.

Laboratory tests as short-term correlates of stroke.

Sughrue T, Swiernik MA, Huang Y, Brody JP.

BMC Neurol. 2016 Jul 21;16:112. doi: 10.1186/s12883-016-0619-y.

16.
17.

A curated and standardized adverse drug event resource to accelerate drug safety research.

Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH.

Sci Data. 2016 May 10;3:160026. doi: 10.1038/sdata.2016.26.

18.

Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records.

Miotto R, Li L, Kidd BA, Dudley JT.

Sci Rep. 2016 May 17;6:26094. doi: 10.1038/srep26094.

19.

Drug-induced adverse events prediction with the LINCS L1000 data.

Wang Z, Clark NR, Ma'ayan A.

Bioinformatics. 2016 Aug 1;32(15):2338-45. doi: 10.1093/bioinformatics/btw168. Epub 2016 Apr 1.

20.

In silico methods for drug repurposing and pharmacology.

Hodos RA, Kidd BA, Shameer K, Readhead BP, Dudley JT.

Wiley Interdiscip Rev Syst Biol Med. 2016 May;8(3):186-210. doi: 10.1002/wsbm.1337. Epub 2016 Apr 15. Review.

Supplemental Content

Support Center